0001209191-11-043272.txt : 20110809 0001209191-11-043272.hdr.sgml : 20110809 20110809194502 ACCESSION NUMBER: 0001209191-11-043272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110805 FILED AS OF DATE: 20110809 DATE AS OF CHANGE: 20110809 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10165 MCKELLAR CT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYANT DOUGLAS C CENTRAL INDEX KEY: 0001406652 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 111022359 MAIL ADDRESS: STREET 1: LUMINEX CORPORATION STREET 2: 12212 TECHNOLOGY BOULEVARD CITY: AUSTIN STATE: TX ZIP: 78727 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2011-08-05 0 0000353569 QUIDEL CORP /DE/ QDEL 0001406652 BRYANT DOUGLAS C 10165 MCKELLAR COURT SAN DIEGO CA 92121 1 1 0 0 President & CEO Common Stock 2011-08-05 4 P 0 20000 13.8904 A 194396 D The weighted average purchase price for these transactions was $13.8904 per share, with a range of $13.815 to $13.90 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price. Robert J. Bujarski, attorney-in-fact for Douglas C. Bryant 2011-08-09